Researchers conducted a pooled analysis of individual patient-level data from 15 trials assessing time to colon ...

IRCCS Ospedale Policlinico San Martino with Mayo Clinic and multiple international cancer research centers have delivered a pooled analysis indicating that colon cancer recurrence risk drops below 0.5 ...

Pastorino and colleagues noted that defining cure in stage II and III colon cancer has been challenging for two reasons: It ...

Tara Sweeney, BSN, RN, OCN, CHPN discussed best care for the health and well-being of a person across all stages of their cancer survivorship. A survivorship program at a community health system is ...

Over the past 20 years, a class of cancer drugs called CD40 agonist antibodies have shown great promise-and induced great disappointment. While effective at activating the immune system to kill cancer ...

Colon cancer recurrence risk falls below 0.5% at 6 years post-surgery, offering a practical benchmark for defining cure, according to new research.